These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 22545160)

  • 1. A research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiases.
    Lustigman S; Geldhof P; Grant WN; Osei-Atweneboana MY; Sripa B; Basáñez MG
    PLoS Negl Trop Dis; 2012; 6(4):e1445. PubMed ID: 22545160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A research agenda for helminth diseases of humans: intervention for control and elimination.
    Prichard RK; Basáñez MG; Boatin BA; McCarthy JS; García HH; Yang GJ; Sripa B; Lustigman S
    PLoS Negl Trop Dis; 2012; 6(4):e1549. PubMed ID: 22545163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A research agenda for helminth diseases of humans: the problem of helminthiases.
    Lustigman S; Prichard RK; Gazzinelli A; Grant WN; Boatin BA; McCarthy JS; Basáñez MG
    PLoS Negl Trop Dis; 2012; 6(4):e1582. PubMed ID: 22545164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A research agenda for helminth diseases of humans: modelling for control and elimination.
    Basáñez MG; McCarthy JS; French MD; Yang GJ; Walker M; Gambhir M; Prichard RK; Churcher TS
    PLoS Negl Trop Dis; 2012; 6(4):e1548. PubMed ID: 22545162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A research agenda for helminth diseases of humans: towards control and elimination.
    Boatin BA; Basáñez MG; Prichard RK; Awadzi K; Barakat RM; García HH; Gazzinelli A; Grant WN; McCarthy JS; N'Goran EK; Osei-Atweneboana MY; Sripa B; Yang GJ; Lustigman S
    PLoS Negl Trop Dis; 2012; 6(4):e1547. PubMed ID: 22545161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A research agenda for helminth diseases of humans: health research and capacity building in disease-endemic countries for helminthiases control.
    Osei-Atweneboana MY; Lustigman S; Prichard RK; Boatin BA; Basáñez MG
    PLoS Negl Trop Dis; 2012; 6(4):e1602. PubMed ID: 22545167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes.
    McCarthy JS; Lustigman S; Yang GJ; Barakat RM; García HH; Sripa B; Willingham AL; Prichard RK; Basáñez MG
    PLoS Negl Trop Dis; 2012; 6(4):e1601. PubMed ID: 22545166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A research agenda for helminth diseases of humans: social ecology, environmental determinants, and health systems.
    Gazzinelli A; Correa-Oliveira R; Yang GJ; Boatin BA; Kloos H
    PLoS Negl Trop Dis; 2012; 6(4):e1603. PubMed ID: 22545168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research priorities for the control and elimination of major helminthiases].
    Qian MB; Chen YD; Zhou XN
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Apr; 31(2):155-9. PubMed ID: 24809202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A research and development agenda for the control and elimination of human helminthiases.
    Utzinger J
    PLoS Negl Trop Dis; 2012; 6(4):e1646. PubMed ID: 22545174
    [No Abstract]   [Full Text] [Related]  

  • 11. Paradigm lost: how parasite control may alter pattern and process in human helminthiases.
    Basáñez MG; French MD; Walker M; Churcher TS
    Trends Parasitol; 2012 Apr; 28(4):161-71. PubMed ID: 22425708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Our wormy world genomics, proteomics and transcriptomics in East and southeast Asia.
    Chuan J; Feng Z; Brindley PJ; McManus DP; Han Z; Jianxin P; Hu W
    Adv Parasitol; 2010; 73():327-71. PubMed ID: 20627147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helminthiases in the People's Republic of China: Status and prospects.
    Brattig NW; Bergquist R; Qian MB; Zhou XN; Utzinger J
    Acta Trop; 2020 Dec; 212():105670. PubMed ID: 32841589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired immune heterogeneity and its sources in human helminth infection.
    Bourke CD; Maizels RM; Mutapi F
    Parasitology; 2011 Feb; 138(2):139-59. PubMed ID: 20946693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ecology of fish parasites with particular reference to helminth parasites and their salmonid fish hosts in Welsh rivers: a review of some of the central questions.
    Thomas JD
    Adv Parasitol; 2002; 52():1-154. PubMed ID: 12521260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in research, control and elimination of helminth infections in Asia.
    Utzinger J; Brattig NW; Leonardo L; Zhou XN; Bergquist R
    Acta Trop; 2015 Jan; 141(Pt B):135-45. PubMed ID: 25446170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity of intestinal helminthiases among malaria outpatients of Wondo Genet health centers, southern Ethiopia: implications for integrated control.
    Tuasha N; Hailemeskel E; Erko B; Petros B
    BMC Infect Dis; 2019 Jul; 19(1):659. PubMed ID: 31340774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important helminth infections in Southeast Asia diversity, potential for control and prospects for elimination.
    Utzinger J; Bergquist R; Olveda R; Zhou XN
    Adv Parasitol; 2010; 72():1-30. PubMed ID: 20624526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research priorities for helminth infections.
    ;
    World Health Organ Tech Rep Ser; 2012; (972):xv-xvii, 1-174, back cover. PubMed ID: 23420950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoendocrine host-parasite interactions during helminth infections: from the basic knowledge to its possible therapeutic applications.
    Hernández-Bello R; Escobedo G; Guzmán C; Ibarra-Coronado EG; López-Griego L; Morales-Montor J
    Parasite Immunol; 2010; 32(9-10):633-43. PubMed ID: 20691015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.